Adverse events: hypertension · patients with Guillain‐Barré syndrome
Corticosteroid leads to lower adverse events ‐ hypertension compared with control (high certainty).
1 finding from 1 review
Death · adults or children with tuberculous meningitis on tuberculosis (TB) chemotherapy
Any corticosteroid leads to lower death compared with control (high certainty).
1 finding from 1 review
Disabling neurological deficit · adults or children with tuberculous meningitis on tuberculosis (TB) chemotherapy
Any corticosteroid showed no clear difference in disabling neurological deficit compared with control (low certainty).
1 finding from 1 review
Change in muscle strength ‐ QMT leg score (lb) · patients with Duchenne muscular dystrophy
1 finding from 1 review
Muscle strength · patients with Duchenne muscular dystrophy
2 findings from 1 review
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
1 finding from 1 review
Change in 4‐stair climbing time · patients with Duchenne muscular dystrophy
1 finding from 1 review
Body‐mass index (BMI) · patients with Duchenne muscular dystrophy
1 finding from 1 review
Behavioural changes · patients with Duchenne muscular dystrophy
1 finding from 1 review
Fractures ‐ not reported · patients with Duchenne muscular dystrophy
1 finding from 1 review
Prolongation of time to loss of ambulation ‐ not reported · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Muscle strength ‐ not reported · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in 4‐stair climbing time · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Weight gain · patients with Duchenne muscular dystrophy
1 finding from 1 review
Behavioural changes · patients with Duchenne muscular dystrophy
It is very uncertain whether deflazacort changes behavioural changes compared with prednisone (very low certainty).
1 finding from 1 review
Fracture · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prolongation of time to loss of ambulation ‐ not reported · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life (AQLQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Serious adverse events 49 weeks · adults with asthma
The intervention showed no clear difference in serious adverse events 49 weeks (low certainty).
1 finding from 1 review